Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder

Schizophrenia Research

Volumn 113, Issue 2-3, 2009, Pages 259-267

  Miller, Christine L ^a   Murakami, Peter ^b   Ruczinski, Ingo ^b   Ross, Randal G ^c   Sinkus, Melissa ^c   Sullivan, Bernadette ^c   Leonard, Sherry ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Gene gene interactions; Metabolic; Niacin receptor; Psychosis; Tryptophan 2,3 dioxygenase

Indexed keywords

HORMONE RECEPTOR; INTERMEDIN; KYNURENINE; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MELANIN CONCENTRATING HORMONE RECEPTOR 2; MELANOCORTIN 5 RECEPTOR; PROTEIN HM74; PROTEIN HM74A; RECEPTOR PROTEIN; TRYPTOPHAN 2,3 DIOXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC REGULATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; DATABASES, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KYNURENINE; LOGISTIC MODELS; MALE; MELANOCYTE-STIMULATING HORMONES; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRYPTOPHAN OXYGENASE; YOUNG ADULT;

EID: 68049135725     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.05.014     Document Type: Article

References (45)

1. Allen N., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., and Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40 (2008) 827-834
2. Baker B.I., and Ball J.N. Evidence for a dual pituitary control of teleost melanophores. Gen. Comp. Endocrinol. 25 (1975) 147-152
3. Barry S., Clarke G., Scully P., and Dinan T.G. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation. J. Psychopharmacol. 23 (2009) 287-294
4. Bednarek M.A., MacNeil T., Tang R., Fong T.M., Cabello M.A., Maroto M., and Teran A. Potent and selective agonists of alpha-melanotropin (αMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin. Peptides 28 (2007) 1020-1028
5. Berrettini W.H. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol. Psychiatry 47 (2000) 245-251
6. Coyle J.T. Glial metabolites of tryptophan and excitotoxicity: coming unglued. Exp. Neurol. 197 (2006) 4-7
7. Dean K., and Murray R.M. Environmental risk factors for psychosis. Dialogues Clin. Neurosci. 7 (2005) 69-80
8. Dick D.M., Foroud T., Flury L., Bowman E.S., Miller M.J., Rau N.L., Moe P.R., Samavedy N., El-Mallakh R., Manji H., Glitz D.A., Meyer E.T., Smiley C., Hahn R., Widmark C., McKinney R., Sutton L., Ballas C., Grice D., Berrettini W., Byerley W., Coryell W., DePaulo R., MacKinnon D.F., Gershon E.S., Kelsoe J.R., McMahon F.J., McInnis M., Murphy D.L., Reich T., Scheftner W., and Nurnberger Jr. J.I. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am. J. Hum. Genet. 73 (2003) 107-114
9. Enoch M.A., Shen P.H., Xu K., Hodgkinson C., and Goldman D. Using ancestry-informative markers to define populations and detect population stratification. J. Psychopharmacol. 20 (2006) 4S19-4S26
10. Erhardt S., Schwieler L., and Engberg G. Kynurenic acid and schizophrenia. Adv. Exp. Med. Biol. 527 (2003) 155-165
11. Freedman R., Olincy A., Ross R.G., Waldo M.C., Stevens K.E., Adler L.E., and Leonard S. The genetics of sensory gating deficits in schizophrenia. Curr. Psychiatry Rep. 5 (2003) 155-161
12. Gottesman I.I., and Shields J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. U. S. A., 58 (1967) 199-205
13. Guidetti P., and Schwarcz R. 3-Hyroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur. J. Neurosci. 11 (1999) 3857-3863
14. Hankes L.V., Leklem J.E., Brown R.R., and Mekel R.C. Tryptophan metabolism in patients with pellagra: problem of vitamin B6 enzyme activity and feedback control of tryptophan pyrrolase enzyme. Am. J. Clin. Nutr. 24 (1971) 730-739
15. Hilmas C., Pereira E.F.R., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21 (2001) 7463-7473
16. Hoffer A., Osmond H., Callbeck M.J., and Kahan I. Treatment of schizophrenia with nicotinic acid and nicotinamide. J. Clin. Exper. Psychopathol. 18 (1957) 131-158
17. Hovatta I., Varilo T., Suvisaari J., Terwilliger J.D., Ollikainen V., Arajärvi R., Juvonen H., Kokko-Sahin M.L., Väisänen L., Mannila H., Lönnqvist J., and Peltonen L. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am. J. Hum. Genet. 65 (1999) 1114-1124
18. Lambert D., Middle F., Hamshere M.L., Segurado R., Raybould R., Corvin A., Green E., O'Mahony E., Nikolov I., Mulcahy T., Haque S., Bort S., Bennett P., Norton N., Owen M.J., Kirov G., Lendon C., Jones L., Jones I., Holmans P., Gill M., and Craddock N. Stage 2 of the Wellcome Trust UK-Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16-q21, 4q12-q21, 9p21, 10p14-p12 and 18q22. Mol. Psychiatry 10 (2005) 831-841
19. Levinson D.F., Holmans P., Straub R.E., Owen M.J., Wildenauer D.B., Gejman P.V., Pulver A.E., Laurent C., Kendler K.S., Walsh D., Norton N., Williams N.M., Schwab S.G., Lerer B., Mowry B.J., Sanders A.R., Antonarakis S.E., Blouin J.L., DeLeuze J.F., and Mallet J. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am. J. Hum. Genet. 67 (2000) 652-663
20. Lin P.I., McInnis M.G., Potash J.B., Willour V.L., Mackinnon D.F., Miao K., Depaulo J.R., and Zandi P.P. Assessment of the effect of age at onset on linkage to bipolar disorder: evidence on chromosomes 18p and 21q. Am. J. Hum. Genet. 77 (2005) 545-555
21. Miller C.L., and Dulay J.R. The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia. Brain Res. Bull. 77 (2008) 33-41
22. Miller C.L., Hruby V.J., Matsunaga T.O., and Bickford P.C. Alpha-MSH and MCH are functional antagonists in a CNS auditory gating paradigm. Peptides 14 (1993) 431-440
23. Miller C.L., Llenos I.C., Dulay J.R., Barillo M.M., Yolken R.H., and Weis S. Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia. Neurobiol. Dis. 15 (2004) 618-629
24. Miller C.L., Llenos I.C., Dulay J.R., and Weis S. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 1073-1074 (2006) 25-37
25. Miller C.L., Llenos I.C., Cwik M., Walkup J., and Weis S. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Neurochem. Int., 52 (2008) 1297-1303
26. Myint A.M., Kim Y.K., Verkerk R., Park S.H., Scharpé S., Steinbusch H.W., and Leonard B.E. Tryptophan breakdown pathway in bipolar mania. J. Affect. Disord. 102 (2007) 65-72
27. Nagamoto H.T., Adler L.E., Waldo M.C., Griffith J., and Freedman R. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schizophr. Res. 4 (1991) 31-40
28. Offen D., Ziv I., Barzilai A., Gorodin S., Glater E., Hochman A., and Melamed E. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease. Neurochem. Int. 31 (1997) 207-216
29. Ruczinski I., Kooperberg C., and LeBlanc M.L. Logic regression. J. Comput. Graph. Stat. 12 (2003) 475-511
30. Saha S., Chant D.C., Welham J.L., and McGrath J.J. The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatr. Scand. 114 (2006) 36-39
31. Schwab S.G., Hallmayer J., Lerer B., Albus M., Borrmann M., Hönig S., Strauss M., Segman R., Lichtermann D., Knapp M., Trixler M., Maier W., and Wildenauer D.B. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am. J. Hum. Genet. 63 (1998) 1139-1152
32. Schwarcz R., Rassoulpour A., Wu H.Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50 (2001) 521-530
33. Severinsen J.E., Als T.D., Binderup H., Kruse T.A., Wang A.G., Vang M., Muir W.J., Blackwood D.H., Mors O., and Børglum A.D. Association analyses suggest GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 524-533
34. Shepard P.D., Joy B., Clerkkin L., and Schwarcz R. Micromolar brain levels of kynurenic acid are associated with disruption of auditory sensory gating in the rat. Neuropsychopharacology 28 (2003) 1454-1462
35. Shink E., Harvey M., Tremblay M., Gagné B., Belleau P., Raymond C., Labbé M., Dubé M.P., Lafrenière R.G., and Barden N. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135 (2005) 50-58
36. Slater A.F., Swiggard W.J., Orton B.R., Flitter W.D., Goldber D.E., Cerami A., and Henderson G.B. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 325-329
37. Soddu G., Sanjust E., Murgia S., and Rescigno A. Interference of some tryptophan metabolites in the formation of melanin in vitro. Pigment Cell Res. 17 (2004) 135-141
38. Stephens S.H., Logel J., Barton A., Franks A., Schultz J., Short M., Dickenson J., James B., Fingerlin T.E., Wagner B., Hodgkinson C., Graw S., Ross R.G., Freedman R., and Leonard S. Association of the 5′-upstream regulatory region of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophrenia Res. 109 (2009) 102-112
39. Tan C.P., Sano H., Iwaasa H., Pan J., Sailer A.W., Hreniuk D.L., Feighner S.D., Palyha O.C., Pong S.S., Figueroa D.J., Austin C.P., Jian M.M., Yu H., Ito J., Ito M., Ito M., Guan X.M., MacNeil D.J., Kanatani A., Van der Ploeg L.H., and Howard A.D. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific expression. Genomics 79 (2002) 785-792
40. Taylor A., and Namba K. In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol. Cell. Biol. 79 (2001) 358-367
41. Torrey E.F., Webster M., Knable M., Johnston N., and Yolken R.H. The Stanley Foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
42. Vawter M.P., Atz M.E., Rollins B.L., Cooper-Casey K.M., Shao L., and Byerley W.F. Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia. Hum. Genet. 119 (2006) 558-570
43. Vazquez S., Garner B., Sheil M.M., and Truscott R.J. Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions. Free Radic. Res. 32 (2000) 11-23
44. Vogliardi S., Bertazzo A., Comai S., Costa C.V., Allegri G., Seraglia R., and Traldi P. An investigation on the role of 3-hydroxykynurenine in pigment formation by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 18 (2004) 1413-1420
45. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130